Polycystic liver disease is a rare genetic condition where multiple fluid-filled cysts develop throughout the liver. Most people never know they have it, as symptoms often don’t appear until around age 50—if they appear at all. However, when cysts become large or numerous, they can cause significant discomfort and affect daily life, making early detection and proper monitoring essential for those at risk.

Introduction: Who Should Seek Diagnostic Testing

If you have a family history of polycystic liver disease, you should consider getting tested even if you feel perfectly healthy. This condition often runs in families, passed from parent to child through genetic changes. Because polycystic liver disease rarely causes symptoms in its early stages, many people discover they have it only by chance during medical tests ordered for other reasons.^[1]

It’s especially important to seek diagnostic evaluation if you have already been diagnosed with polycystic kidney disease. About 70% of people with polycystic liver disease also have cysts in their kidneys, a condition known as autosomal dominant polycystic kidney disease (or ADPKD for short). This means the two conditions often occur together, and doctors need to check both organs to understand the full picture of your health.^[1]

You should also talk to your doctor about testing if you’re experiencing certain symptoms that could suggest your liver has become enlarged with cysts. These symptoms include a feeling of fullness in your upper abdomen, abdominal pain or swelling, difficulty eating normal amounts of food, or shortness of breath. Sometimes people also experience back pain or heartburn when a greatly enlarged liver presses on surrounding organs and tissues.^[1]

Women should be particularly aware of this condition. Females are much more likely than males to develop symptoms and severe disease, partly because the hormone estrogen appears to stimulate cyst growth. If you’re a woman with a family history of polycystic liver disease, regular check-ups become even more important as you reach middle age, when symptoms typically begin to appear if they’re going to occur at all.^[2]

If a doctor has diagnosed you with ADPKD, they should offer you a liver scan to check for liver cysts, even if you don’t have symptoms. This proactive approach helps catch any liver involvement early, allowing you and your healthcare team to monitor the condition over time and plan treatment if needed. Most people with ADPKD have liver cysts by their mid-thirties, though they may not cause any problems.^[16]

Classic Diagnostic Methods for Polycystic Liver Disease

The diagnosis of polycystic liver disease begins with imaging tests that allow doctors to see inside your liver and count the cysts present. The most common first test is an ultrasound, a painless procedure that uses sound waves to create pictures of your liver. Ultrasound is often chosen as the initial test because it’s widely available, doesn’t use radiation, and can clearly show fluid-filled cysts within the liver tissue.^[4]

If more detailed images are needed, doctors may order a CT scan (computed tomography) or an MRI (magnetic resonance imaging). These tests provide much more detailed, three-dimensional images of your liver and can help doctors measure exactly how large your liver has become and how many cysts are present. The CT scan uses X-rays to create cross-sectional images, while MRI uses powerful magnets and radio waves. Both are excellent for assessing polycystic liver disease, though MRI is particularly useful for evaluating patients without exposing them to radiation.^[2]

When doctors review your imaging results, they look for specific criteria to confirm the diagnosis. The actual number of cysts needed for diagnosis depends on your age and family history. If you have a family member with polycystic liver disease and you’re under age 40, doctors may diagnose you if they find more than one cyst. If you’re over 40 with a family history, more than three cysts would confirm the diagnosis. For people with no family history of the disease who are over 40, doctors typically require seeing more than 20 cysts before making the diagnosis.^[4]

Your medical history plays a crucial role in the diagnostic process. Doctors will ask detailed questions about whether anyone in your family has had polycystic liver disease, polycystic kidney disease, or required liver or kidney transplants. Because this is a genetic condition that follows an autosomal dominant pattern (meaning you only need to inherit one changed gene from one parent to develop the condition), family patterns are very informative. If multiple family members have the condition, it strongly suggests you might have inherited the genetic changes responsible.^[1]

A physical examination is another important part of diagnosis. Your doctor will carefully feel your abdomen to check if your liver is enlarged or if they can feel any large cysts near the liver’s surface. An enlarged liver can sometimes be felt extending below the ribcage. The doctor will also check for signs of complications, such as fluid buildup in the abdomen (called ascites) or tenderness that might suggest a cyst has become infected or ruptured.^[9]

Blood tests are typically performed as part of the diagnostic workup, though they serve a different purpose than imaging. Interestingly, most people with polycystic liver disease have completely normal liver function tests, even when their liver is massively enlarged with cysts. This happens because the cysts don’t usually damage the working liver tissue that remains. Blood tests mainly help doctors rule out other liver conditions and check for complications. They may include tests for liver enzymes, bilirubin (which can indicate bile duct blockage), and proteins made by the liver.^[9]

Distinguishing between isolated polycystic liver disease and polycystic liver disease associated with kidney disease is critical for your long-term health outlook. If you’re diagnosed with liver cysts, doctors must check your kidneys as well. This typically involves an abdominal MRI that images both organs, or separate kidney imaging if only your liver was initially scanned. If no kidney cysts are found, or if there aren’t enough kidney cysts to meet the criteria for polycystic kidney disease, your condition is classified as isolated polycystic liver disease. This distinction matters because people with isolated disease have better long-term outcomes overall, mainly because they avoid the kidney failure complications that can occur with ADPKD.^[3]

In some cases, doctors may recommend genetic testing to identify the specific gene mutations causing your condition. Several genes are known to cause polycystic liver disease, including PRKCSH and SEC63 for isolated disease, and PKD1 and PKD2 for disease associated with polycystic kidney disease. However, these identified genes account for less than half of all cases, meaning many other genes are likely involved but haven’t been discovered yet. Genetic testing can be helpful for family planning decisions or when the diagnosis is uncertain based on imaging alone.^[1]

The diagnostic process also involves looking for possible complications of polycystic liver disease, even if they’re rare. Doctors may check for signs of cyst infection, which can cause fever and severe abdominal pain. They’ll also look for evidence of bile duct obstruction, which occurs when large cysts press on the tubes that carry bile from the liver. This can cause jaundice—a yellowing of the skin and eyes. Rarely, doctors need to check for internal bleeding if a cyst has ruptured, though this is an uncommon complication.^[4]

Diagnostic Tests for Clinical Trial Qualification

When patients with polycystic liver disease are being considered for enrollment in clinical trials, they typically undergo more specialized and standardized diagnostic testing than in routine clinical care. These tests help researchers select appropriate participants and measure whether experimental treatments are working.

Advanced imaging with precise liver volume measurements is standard for clinical trial qualification. Research studies often require calculation of total liver volume using special computer software that analyzes CT or MRI scans. This software traces the outline of the liver on each image slice and adds up all the measurements to calculate the total volume in milliliters. Researchers use this number as a baseline to compare against later measurements to see if an experimental treatment reduces liver size. Some trials only accept patients whose livers have reached a certain size, as these individuals are most likely to have symptoms and potentially benefit from treatment.^[6]

Classification systems are often used in clinical trials to categorize patients by disease severity. Two commonly used systems are the Gigot classification and the Schnelldorfer classification. These systems evaluate factors like how many cysts you have, how large they are, how much normal liver tissue remains, and whether the cysts are spread throughout the liver or clustered in certain areas. By categorizing patients this way, researchers can study whether treatments work differently depending on disease stage and ensure they’re comparing similar groups of patients.^[8]

Clinical trials often have strict criteria about liver function. Even though most people with polycystic liver disease have normal liver function, trials will typically require multiple blood tests to confirm this. These may include comprehensive metabolic panels that measure liver enzymes (such as ALT and AST), bilirubin levels, albumin (a protein made by the liver), and prothrombin time (which measures how well your blood clots and depends on proteins made by the liver). Trials want to ensure participants don’t have underlying liver damage that could interfere with study results or put them at risk.^[2]

For trials involving medications like somatostatin analogues (such as octreotide or lanreotide), researchers typically select patients with the most severe symptoms and largest liver volumes. These injectable medications are being studied for their ability to reduce liver size and relieve symptoms like abdominal fullness and pain. Trial participants usually need to have documented symptoms affecting their quality of life and liver volumes significantly larger than normal. Baseline quality-of-life questionnaires help researchers measure whether symptoms improve during treatment.^[3]

Kidney function assessment is particularly important for clinical trials, especially when the polycystic liver disease occurs with ADPKD. Researchers need to know whether participants have kidney cysts, how well the kidneys are functioning, and whether kidney disease is progressing. This may involve blood tests for creatinine and estimated glomerular filtration rate (eGFR), urine tests for protein, and kidney imaging to count and measure cysts. Some trials specifically study whether treating liver cysts might indirectly benefit kidney function, or vice versa.^[14]

Serial imaging over time is a requirement in most polycystic liver disease clinical trials. Participants typically undergo CT or MRI scans at specific intervals—perhaps at enrollment, then at 6 months, 12 months, and so on—to track changes in liver volume. Researchers compare these images to determine whether the experimental treatment is slowing cyst growth or actually shrinking the liver. This repeated imaging provides objective evidence of treatment effectiveness beyond just asking patients how they feel.^[14]

Some research studies also require genetic confirmation of the diagnosis through blood tests that identify specific gene mutations. This is particularly important in trials studying treatments targeting specific genetic pathways. For example, a trial might only enroll patients with mutations in the PKD1 or PKD2 genes, or in the PRKCSH or SEC63 genes, depending on what mechanism the experimental treatment is designed to address. Genetic testing helps ensure the study population is appropriate for the treatment being tested.^[2]